This Wall Street Veteran Bets Big on Avalanche Now
A seasoned Wall Street investor reveals a sizable bet on Avalanche, arguing the platform’s treasury mechanics and sca...
Which Bond Funds To Hold In Retirement Taxable Or Tax Exempt
This article helps you decide between taxable and tax-exempt bond funds in retirement, outlining allocation strategies and tax considerations.
25,011 articles
OpenAI Engineer’s ‘Lol’ Moment Sparks Apple Lawsuit
A new lawsuit alleges a former Apple engineer leveraged a bug to access internal files after joining OpenAI, promptin...
Chipotle Stock Topped Market as Growth Signals Spark Rally
Chipotle stock topped market today as investors cheered a mix of global expansion news, digital growth, and improving...
Warren Buffett's Successor, Greg: Abel's Notable Q2 Moves
As Berkshire's new investment captain, Greg Abel faces a pivotal test: can his Q2 moves in Alphabet, Mitsubishi, Maru...
Amazon’s Trillion-Dollar Capex Gamble vs Lean Shopify
Amazon and Shopify posted contrasting Q1 2026 results, underscoring a widening gap between a capital-heavy expansion ...
Stock That Could Turn AI Markets: Snowflake Emerges
A high-potential, under-the-radar AI stock could turn the tide against the giants. Snowflake blends data cloud power ...
Real Reason Investors Should Be Excited by Ford's China Talks
Ford's China negotiations could redefine its growth trajectory. This article explains the real reason investors shoul...
Madrigal (MDGL) 2025 Earnings: What Investors Should Know
As Madrigal prepares to report its 2025 earnings, investors weigh pipeline progress, cash runway, and milestones ahea...
Urban Outfitters’ Namesake Turnaround Drives Q4 Sales
Urban Outfitters’ namesake stores are lifting results as fourth-quarter earnings beat expectations, signaling a broad...
MARA Shares Rise After AI Data Center Deal Sparks Rally
A bitcoin miner is branching into AI infrastructure, and the market has taken notice. The plan to turn U.S. sites int...
UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Forget Crispr Therapeutics: This Gene-Editing Pick Attracts
The gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status